KCTD11 Tumor Suppressor Gene Expression Is Reduced in Prostate Adenocarcinoma
Figure 2
KCTD11 expression in prostate cancer cells compared to normal cells. (a) Total KCTD11-positive cells in normal and prostate adenocarcinoma tissues. (b) Nuclear KCTD11-positive cells in normal and prostate adenocarcinoma tissues. () (c) Cytoplasmic KCTD11-positive cells in normal and prostate adenocarcinoma tissues. ((a)–(c)) Data are mean ± S.D. (d) KCTD11, Gli1, and Patch1 expressions in normal ((A), (B), and (C)) and prostate adenocarcinoma ((D)–(I)). Magnification 40x.
